We recently published 10 Big Names With Double-Digit Upsides. Oscar Health, Inc. (NYSE:OSCR) is one of last week’s top performers.
Oscar Health jumped by 16.63 percent week-on-week, as investor sentiment was fueled by the company’s reaffirmation of its full-year 2025 growth guidance.
At the 2025 Wells Fargo Healthcare Conference in Boston, Massachusetts, held last September 3 to 5, Oscar Health, Inc. (NYSE:OSCR) reaffirmed its key growth metrics for the full year, including a revenue growth guidance of $11.2 billion to $11.3 billion and operating income of $225 million to $275 million.
Sebastian Kaulitzki/Shutterstock.com
“We believe the individual market has long-term upside and is the future of healthcare,” said Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini during the company’s earnings report.
“Oscar is well-positioned to manage through the market reset in 2025. We believe the market will stabilize next year and expect to return to profitability in 2026. We are building the individual market into a healthcare marketplace for more consumers and businesses, and continue to position the company for long-term growth,” he added.
In the second quarter of the year, Oscar Health, Inc. (NYSE:OSCR) swung to a net loss of $228.49 million from a $56.3 million net income in the same period last year. Revenues increased by 28.8 percent to $2.86 billion from $2.22 billion year-on-year.
While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
